Clinical significance of MET alterations in non-small cell lung cancer and currently available therapies | Smolin | Malignant tumours

Malignant tumours
Zlokačestvennye opuholi

ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)

eng | рус

Preview

Malignant tumours

Advanced search

Archives

Download this PDF file

For citations:

Smolin S.А., Zhukova L.G., Smolin А.V., Bubenko D.N., Grechukhina К. . Clinical significance of MET alterations in non-small cell lung cancer and currently available therapies. Malignant tumours. 2023;13(3):37-48. (In Russ.) https://doi.org/10.18027/2224-5057-2023-13-3-37-48

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Nosov D.A.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

S. А. Smolin
A. S. Loginov Moscow Clinical Scientific Center
Russian Federation

Sergei A. Smolin, Oncologist, Research Fellow, Department of Chemotherapy

Moscow

L. G. Zhukova
A. S. Loginov Moscow Clinical Scientific Center
Russian Federation

Lyudmila G. Zhukova, MD, PhD, DSc, Professor, Corresponding Member of the Russian Academy of Sciences, Deputy Director for Oncology

Moscow

А. V. Smolin
N. N. Burdenko Central Military Clinical Hospital
Russian Federation

Aleksei V. Smolin, Head of the Radiology Center

Moscow

D. N. Bubenko
A. S. Loginov Moscow Clinical Scientific Center
Russian Federation

Dmitry N. Bubenko, Clinical Resident, Chemotherapy Department

Moscow

К. S. Grechukhina
A. S. Loginov Moscow Clinical Scientific Center; Central State Medical Academy
Russian Federation

Katerina S. Grechukhina, MD, PhD, Head of the Chemotherapy Department; Assistant of the Department of Clinical Oncology

Moscow

Notifications